Mounjaro costs $499 a month, and compounded alternatives start at $125

Brand Mounjaro costs you $499 a month at every strength through LillyDirect self-pay, against a $1,112.16 list price.

With commercial insurance that covers Mounjaro, Lilly's savings card brings a fill to as little as $25. Compounded tirzepatide costs less, but it is not FDA-approved and is not the same finished product as Mounjaro.

  • $499a month at every strength through LillyDirect self-pay, prescription required
  • $25for up to a 3-month fill when your commercial plan covers Mounjaro
  • $125a month for compounded tirzepatide at Trimi Health, not FDA-approved

We checked LillyDirect's Mounjaro price on October 15, 2026 and Lilly's savings terms on October 15, 2026. Each program price below carries its own check date.

Pricing it out? See the savings-card and coupon routes and the label's dose schedule.

These are partners we chose. They do not include every listed program or guarantee the lowest total cost. We may earn a commission when you join. That never changes a score or a price order.

Not sure this is your medicine? Take the 60-second quiz

What is Mounjaro?

Mounjaro is Eli Lilly's brand of tirzepatide, a once-weekly injection approved for type 2 diabetes.

Active ingredient
Tirzepatide, which activates two gut-hormone receptors, GIP and GLP-1
How you take it
One injection a week
Approved for
Adults with type 2 diabetes, to improve blood sugar alongside diet and exercise. Prescribing it for weight loss alone is off-label.
Same molecule as
Zepbound, which is approved for chronic weight management
Lilly self-pay price
Yes, $499 a month at every strength through LillyDirect, prescription required

Compounded products can list tirzepatide too, but a pharmacy makes them, not Lilly. They are not FDA-approved, and the same ingredient name doesn't mean the same quality or results.

We read the approval from the Mounjaro label on DailyMed.

What does Mounjaro cost through LillyDirect or with Lilly's savings card?

Lilly sells Mounjaro single-dose pens for self-pay through LillyDirect at one price for every strength, and the savings card cuts a fill further when your commercial plan covers it.

  • LillyDirect self-pay, any strength$499Starting price for a 28-day supply of single-dose pens, with or without insurance. You need a prescription.
  • Your commercial plan covers Mounjaroas little as $25For a 1-, 2- or 3-month fill. Savings cap $450 per 3-month prescription and $1,950 a year.
  • Your commercial plan does not cover itas low as $499For a 1-month fill, on the same card.
  • List price$1,112.16A month before any card or plan. Medicare and Medicaid enrollees cannot use the card.

The card expires and savings end on December 31, 2026. Our Mounjaro coupon page lists every term.

We read the self-pay price on LillyDirect's Mounjaro page on October 15, 2026. We checked Lilly's Mounjaro savings terms on October 15, 2026.

What do telehealth programs charge for brand Mounjaro?

Programs that sell Mounjaro start at $249 a month, but 3 of the 7 prices below leave out the medicine, a membership or another cost.

Each price here is the program's own price for Mounjaro, never its cheaper compounded headline.

Mounjaro programs, cash prices and listed tiers
ProgramCash priceTier as listed
bmiMD$249/molowest plan price, may need a longer planMounjaro (brand-name)
SynergyRx$947/moask for the full billBrand-Name Wegovy/Mounjaro
TrimRx$1,249/mofees or medicine billed on topBrand Zepbound or Mounjaro package
Maximus$1,249.99/mofees or medicine billed on topBrand Mounjaro
DudeMeds$1,350/momonthly priceBrand-name Zepbound or Mounjaro
Eden Health GLP-1$1,399/momonthly priceBrand Zepbound/Mounjaro/Ozempic (cash)
Wellorithm$1,399/4 weekslowest plan price, may need a longer planBrand Mounjaro Pen

Each program's review shows the date we last checked its price.

What are the Mounjaro alternatives, ranked by verified price?

Compounded tirzepatide costs $209 a month at the lowest flat price, and none of it is FDA-approved.

A compounding pharmacy makes these products, not Lilly. Each price here includes the medicine and stays the same every month, with no intro rate, prepay or extra fee. For every plan length, see the full tirzepatide price list.

We sort by price, never by who pays us (how we rank). We last re-checked one of these prices on September 3, 2026.

What can you do if you can't afford Mounjaro?

Work through these routes in order, starting with the ones that keep you on brand Mounjaro.

Check, in this order:

  • If your commercial plan covers Mounjaro, enroll in Lilly's savings card and pay as little as $25.
  • If your commercial plan does not cover it, the same card brings a 1-month fill to as low as $499.
  • If you pay cash, compare LillyDirect's $499 a month with any program's total, membership included.
  • If your prescription is for weight management rather than diabetes, ask your prescriber about Zepbound, whose LillyDirect self-pay price starts lower, at $299 for the 2.5 mg starting dose.
  • If you have Medicare, check your Part D plan's formulary for Mounjaro's approved use; the savings card excludes you.
  • If you consider compounded tirzepatide, remember it is not FDA-approved, and ask your prescriber whether it suits you.

Is compounded tirzepatide the same as Mounjaro?

No. A compounded product may list tirzepatide as its active ingredient, but it is not the same finished product as Mounjaro.

Mounjaro is an FDA-approved product that Lilly makes and tests as a whole. A pharmacy makes a compounded version for one patient, and the FDA does not review it for safety, effectiveness or quality.

No head-to-head trial shows the two work the same. Our brand versus compounded guide covers what the FDA has actually said.

Questions people ask about Mounjaro

What is Mounjaro?

Mounjaro is Eli Lilly's brand of tirzepatide, a once-weekly injection that activates the GIP and GLP-1 receptors.

It is approved for type 2 diabetes, and Zepbound is the same molecule approved for chronic weight management.

Is there a cheaper alternative to Mounjaro?

Yes.

Compounded tirzepatide costs less: the lowest flat monthly price is $209 at Bodybuilding Health+, against $249 a month for the lowest brand Mounjaro price a program publishes (lowest plan price, may need a longer plan). A compounded product is not FDA-approved, and a lower price doesn't make it the same medicine.

Is Mounjaro the same as Zepbound?

Yes, the molecule is the same: both are Lilly's tirzepatide.

Mounjaro is approved for type 2 diabetes and Zepbound for chronic weight management. Their LillyDirect self-pay prices differ: Zepbound starts at $299 a month at the 2.5 mg starting dose and rises with your dose, while Mounjaro is $499 a month at every strength.

Does insurance cover Mounjaro?

It depends on your plan.

Check your plan's formulary for Mounjaro, which is approved for type 2 diabetes. If your commercial plan covers it, Lilly's savings card can bring a fill to as little as $25; if your commercial plan does not, the card brings a 1-month fill to as low as $499. Without coverage, LillyDirect sells Mounjaro for self-pay at $499 a month at every strength.

Is there a natural alternative to Mounjaro?

No.

Dietary supplements such as berberine are not approved medicines, and the FDA does not approve supplements before they are sold. Talk to your prescriber before you replace or add anything. The FDA explains how supplements are regulated, and our berberine explainer covers the most common claim.

Prices on this page come from our own index of 38 GLP-1 programs and from Lilly's pages on the dates shown. This page gives you information, not medical advice.

Featured Partners

Affiliate partners we feature. We may earn a commission.

bmiMD

from $249/mo·Brand & Compounded

Mounjaro (brand-name); lowest plan price, may need a longer plan

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.